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1. INTRODUCTION 
Phagocytosis is a key process in combatting in- 
fections in man and animals, and polymorphonu- 
clear leucocytes (PMN) are of particular import- 
ance in this event. The plasma membrane of PMN 
plays a central part in phagocytosis. An important 
step in host defence by phagocytic PMN is an en- 
hanced production of excited oxygen species ]I] 
which takes place when resting cells are exposed to 
various activating agents such as bacteria and other 
particles, chemotactic peptides, the calcium iono- 
phore A 23 187 and certain complement components 
[2]. A particularly powerful activating agent is the 
tumor promoting phorbol-12-myristate-13-acetate 
(PMA) (31. 
Several events, including generation of superoxide 
radicals (0~~), microtubule assembly, degranula- 
tion, enzyme secretion, release of arachidonic acid 
and its metabolites, and changes in cell membrane 
potential are initiated in the plasma membrane 
upon stimulation of resting PMN. Little is known 
about the exact sequence of these events and the 
mode of signal transfer between the stimulus and 
the cellular response. Here, we used the fluor- 
escence anisotropy of the lipophilic probe diphenyl- 
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hexatriene (DPH) to study possible physical changes 
of the PMN plasma membrane upon exposure to 
PMA. The results indicate a rapid and dramatic 
increase in the order of the membrane lipid domain 
upon exposure of the plasma membrane to this 
stimulus. 
2. MATERIALS AND METHODS 
Chemicals were obtained from the following 
sources: Fluka (Buchs), 1,6-diphenyl- 1,3,5-hexa- 
triene; Sigma (St Louis), 4P-phorbol 12&myristate 
13cu-acetate; Pharmacia Fine Chemicals (Uppsala), 
Percoll, dextran T-500; Boehringer (Mannheim), 
cytochrome c (horse heart, salt free), nicotinamide 
adenine dinucleotide phosphate (reduced form, te- 
trasodium salt). 
2.1. Isolation of PMN 
Blood from healthy donors was collected and 
mixed with 6% dextran T-500 solution containing 
0.9% of NaCl (5:1, v/v). After 30 min, the upper 
phase was removed and layered on a Percoll gra- 
dient and centrifuged for 20 min at 350 x g accord- 
ing to 141. After centrifugation the granulocyte 
band (< 97% PMN) was collected, and the cells 
were washed twice in HBSS (calcium free). The 
viability of the cells was determined by trypan blue 
exclusion and found to be z 97%. 
2.2. Isolation ofplasma membrane 
The procedure in [5] was followed except that the 
cells were ruptured by mild sonification on ice (3 x 
10 s with the lowest energy output of a Branson type 
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sonitier). Rat liver mitochondria and microsomes 
were prepared according to [6] and [7], respectively: 
the membrane of human red blood cells was isola- 
ted as in [S]. 
2.3. Fluorescence polarization measurements 
Cells or the isolated membrane fractions (80- 100 
pg protein) were suspended in 3 ml HBSS and 
labeled for 20 min at 37°C with 2 PM DPH (2 mM 
stock solution in tetrahydrofuran). Steady state 
fluorescence anisotropy was measured with con- 
stant stirring in an Aminco SPF-500 spectrofluoro- 
meter. The sample was excited by a vertically polar- 
ized light at 357 nm, and the sample fluorescence 
at 430 nm was analyzed by using optical filters (cut 
off 420 nm) and the monochromator into vertically 
and horizontally polarized components Iv and 1~. 
The steady state anisotropy, 9, is obtained as: 
? = (Iv - I#(&, + 21H) 
019 
017 
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013 
For each measurement of rs, IV and IH were 
corrected for intrinsic fluorescence, light scattering 
and instrumental factors. 
2.4. Production of O>- 
The production of superoxide anion was contin- 
uously followed by the cytochrome c reduction as- 
say 191. 
2.5. Challenge with PMA 
PMA (stock solution 2 mg/ml in dimethyl sulf- 
oxide) was added to cells or membranes to give 1 PLg 
or 330 ng/ml final cont. as indicated in section 3. 
The first determination of rs of DPH was performed 
within 8 s after addition of PMA. 
3. RESULTS 
When resting intact PMN were stimulated with 1 
pg PMA/ml, a small and rapid increase of the 
PMA 
t 
! lilm- 
-2 0 
time (min) 
F&l. Steady-state fluorescence anisotropy (9) of DPH in the plasma membrane fraction of PMN upon stimulation by 1 
fig PMA/ml. Cells were labeled with DPH for 20 min at 37°C in HBSS as in section 2 prior to the addition of PMA 
(indicated by the arrow). The result shown is representative of 3 separate experiments (+ SD) each performed in 
duplicate. 
200 
Volume 144, number 2 FEBS LETTERS August 1982 
fluorescence anisotropy (?) of DPH above a resting 
value of 0.18 was usually observed. It was essen- 
tially complete within 30 s. The increased ? could 
be observed for 2 10 min. When smaller amounts 
(330 q/ml) of PMA were used the increase of ? 
was transient and could be evoked repetitively. The 
amount of O;- produced by these cells upon stim- 
ulation, as measured by superoxide dismutase- 
inhibitable cytochrome c reduction, ranged from 
50-70 nmol/min and mg protein. 
DPH is known to incorporate spontaneously into 
all cellular membranes. The plasma membrane, 
which has been shown to contain receptors specific 
for PMA [ IO,1 l] constitutes, however, only a minor 
fraction of all membranes present in cells. There- 
fore the fluorescence polarization of DPH was also 
measured in the isolated plasma membrane frac- 
tion. Fig. 1 shows that addition of PMA to the plasma 
membrane fraction isolated from resting PMN 
results in a rapid and very pronounced increase of? 
of DPH from 0.14-o. 19. The fluorescence intensity, 
determined as Iv + 21~1, of DPH increased 
- 1.8-fold upon PMA challenge. Identical results 
were obtained with the plasma membrane fraction 
isolated from PMN exposed to 1 fig PMA/ 10’ cells 
for 3 min at 37°C prior to sonification of the cells 
(not shown). The increased rS value in the stimula- 
ted plasma membrane fraction is lasting. Thus, 
when the stimulated plasma membrane fraction has 
been stored for 21 and 48 h, rS was 0.18 and 0.17, 
respectively. The amount of cytochrome c reduced 
by the plasma membrane fraction in the presence of 
1 mM NADPH was 7 nmol/min and mg protein, 
30% of which were inhibitable by superoxide dis- 
mutase. 
The specificity of the observed increase of rs of 
DPH in the stimulated plasma membrane fraction 
is supported by the results shown in lig.2. PMA has 
no or only a minor influence on the fluorescence 
anisotropy of DPH imbedded in membranes of rat 
liver mitochondria or microsomes, or membranes of 
human red blood cells. No change of the fluor- 
escence intensity of DPH upon addition of PMA 
was observed in these membranes. 
The observed increase in ? is not due to possible 
chemical reactions or degradation of DPH mol- 
ecules upon stimulation of the plasma membrane 
fraction, as judged by the following control experi- 
ments: An ?-value of 0.19 was also obtained when 
the isolated plasma membrane fraction was first 
stimulated with PMA and then labeled with DPH. 
Also, the shape of the fluorescence emission spec- 
trum was the same regardless whether DPH was 
added before or after stimulation of the plasma 
membrane fraction by PMA (fig.3). The stimulation 
results in an increased fluorescence intensity. 
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Fig.2. Steady-state fluorescence anisotropy (rS) of DPH in 
rat liver microsomes (a), mitochondria (b), and mem- 
branes of human red blood cells (c) challenged with 1 PLg 
PMA/ml. Measurements were performed as in fig.1. 
Each value represents the mean of 3 (a,b) and 4 (c) 
separate experiments (2 SD). 
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380 460 540 nm 
Fig.3. Fluorescence mission spectra of DPH’in the plasma membrane fraction before (-) and after stimulation (- - -) by 
PMA. When adding DPH (2 PM) 5 min after stimulation of the plasma membrane fraction by PMA the emission spectrum 
(-.-.-) was recorded. In each experiment he plasma membrane fraction was labeled with DPH by an incubation for 20 min 
at 37°C. Excitation wavelength was 357 nm, the excitation and emission slits were 5 nm and 10 nm, respectively. 
4. DISCUSSION 
The steady state fluorescence polarization of 
DPH in membranes can be used as an indicator of 
the degree of order of membrane-lipid fatty acid 
chains, if certain precautions are taken [12-141. 
Here, we show that stimulation by PMA increases 
the steady state fluorescence anisotropy, rS, of DPH 
in intact human PMN. A dramatic increase of rs is 
observed in the isolated plasma membrane fraction. 
The increase of rS can result either from a decreased 
life-time of the excited DPH molecules, or an in- 
crease of the order of the fatty acid chains surround- 
ing the DPH molecules. The former possibility can 
be excluded in our experiments by the observation 
that the fluorescence intensity of DPH increases 
upon stimulation, because the fluorescence life- 
time is approximately proportional to the fluor- 
escence intensity 1121. Since significant changes in 
the ? value of DPH in mitochondria, microsomes, 
and membranes of red blood cells are absent after 
stimulation by PMA its action appears specific for 
the plasma membrane of PMN. The results suggest 
that PMA causes a specific, rapid and extensive 
increase in the order of the lipid domain of the 
PMN plasma membrane. Definite proof of the in- 
creased order will be provided by time-resolved 
fluorescence polarization measurements. 
After exposure of PMN with activating agents, 
the time required for the conversion from the rest- 
ing to the fully stimulated state is between 20-70 s 
[ 11. The observed increase of rS is clearly detectable 
after 10 s, half-maximal after -30 s and complete 
after -2-3 min. The earliest events (e.g., changes 
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in membrane potential and calcium mobilization) 
observed so far also take place 5-10 s after stimu- 
lation [ 15,161. The temporal sequences of these 
early responses have not been resolved so far. 
The molecular events responsible for the increased 
order of the membrane lipid fatty acid chains 
after PMA stimulation are not known. The primary 
target of PMA in the plasma membrane is a protein 
receptor. It can be expected that the binding of the 
ligand to the receptor somehow transfers a signal to 
other proteins in the membrane (e.g., NADPH 
oxidase or a b-type cytochrome) involved in phago- 
cytosis. Whether the transfer is mediated by an in- 
crease in the order of the lipid domain, or whether 
the observed increase is secondary to protein-pro- 
tein interactions remains to be established. 
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